Resistance to use of perioperative β-blockers: A no-man's land [3]

Archives of Internal Medicine

Volumn 165, Issue 3, 2005, Pages 347-

  Grupper, Avishay ^b   Brezis, Mayer ^a  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT;

CLINICAL TRIAL; CORONARY ARTERY DISEASE; HEALTH SERVICE; HUMAN; LETTER; MEDICAL STAFF; PERIOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY CONTROL; SAFETY;

ADRENERGIC BETA-ANTAGONISTS; CORONARY DISEASE; DRUG UTILIZATION; HUMANS; ISRAEL; PERIOPERATIVE CARE; PHYSICIAN'S PRACTICE PATTERNS; POSTOPERATIVE COMPLICATIONS; PROSPECTIVE STUDIES;

EID: 13444268969     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Letter

References (3)

1. Siddiqui AK, Ahmed S, Delbeau H, Conner D, Mattana J. Lack of physician concordance with guidelines on the perioperative use of β-blockers. Arch Intern Med. 2004;164:664-667.
2. Auerbach AD. Beta-blockers and reduction of perioperative cardiac events. In: Shojania KG, Duncan BW, McDonald KM, et al, eds. Making Health Care Safer: A Critical Analysis of Patient Safety Practices: Evidence Report/Technology Assessment No. 43 (prepared by the University of California at San Francisco-Stanford Evidence-based Practice Center under Contract No. 290-97-0013). Rockville, Md: Agency for Healthcare Research and Quality; July 2001:271-280. AHRQ publication 01-E058.
3. Devereaux PJ, Yusuf S, Yang H, Choi PT, Guyatt GH. Are the recommendations to use perioperative beta-blocker therapy in patients undergoing non-cardiac surgery based on reliable evidence? CMAJ. 2004;171:245-247.